Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ACE inhibitor for proteinuria in cyanotic congenital heart disease
TCTR20180208003Phase 3Not yet recruiting
- Sponsor
- Faculty of Medicine, Chiang Mai University
- Start
- May 2018
- Countries
- 1
01
Overview
Phase 3 trial in proteinuria and Cyanotic heart disease (CCHD), sponsored by Faculty of Medicine, Chiang Mai University. Planned start May 2018; status: not yet recruiting.
02
Conditions
proteinuriaCyanotic heart disease (CCHD)
Beyond the preview
Go deeper on TCTR20180208003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20180208003.